retatrutide phase 2 trial results weight loss of a new medication, Retatrutide, showed the highest amount of in a clinical so far. 24% of body weight lost. An average of 58 pounds over 48 weeks! The medical management of Lilly orforglipron oral GLP-1 phase

Mechanisms of Action and Benefit Biological, Physiological, and Molecular Considerations Glucagon-like peptide 1 (GLP-1) is primarily secreted by enteroendocrine L-cells in the intestine, pancreatic -cells, and the central nervous system (CNS) [26]

If the code indicates obesity (E66.x) rather than diabetes (E11.x) or sleep apnea (G47.33), the claim auto-rejects with "Reject Code 88: Use is not medically accepted." You can, but it's unlikely to succeed for plan exclusions

& Matsui, H

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials

Watch your bodys dashboard, not just the scale